The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides-Reference-Cited by-同舟云学术

The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides

Published:2009-06-01 Issue:6 Volume:94 Page:1843-1852
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Abu-Hamdah Rania¹,Rabiee Atoosa¹²,Meneilly Graydon S.³,Shannon Richard P.⁴,Andersen Dana K.¹,Elahi Dariush¹²

Affiliation:

1. Johns Hopkins University School of Medicine, Departments of Surgery (R.A.-H., A.R., D.K.A., D.E.), Johns Hopkins Bayview Medical Center, Baltimore, Maryland 21224-2780

2. Medicine (A.R., D.E.), Johns Hopkins Bayview Medical Center, Baltimore, Maryland 21224-2780

3. University of British Columbia (G.S.M.), Department of Medicine, Vancouver, British Columbia, Canada V5Z 1M9

4. University of Pennsylvania School of Medicine (R.P.S.), Department of Medicine, Philadelphia, Pennsylvania 19104-2646

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/94/6/1843/9062364/jcem1843.pdf

Reference118 articles.

1. The multiple faces of glucagon-like peptide-1–obesity, appetite, and stress: what is next? A review.;Frezza;Dig Dis Sci,2007

2. Hamster preproglucagon contains the sequence of glucagon and two related peptides.;Bell;Nature,1983

3. Mammalian pancreatic preproglucagon contains three glucagon-related peptides.;Lopez;Proc Natl Acad Sci USA,1983

4. Pre-proglucagon messenger ribonucleic acid: nucleotide and encoded amino acid sequences of the rat pancreatic complementary deoxyribonucleic acid.;Heinrich;Endocrinology,1984

5. Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.;Mojsov;J Clin Invest,1987

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single‐Administration Self‐Boosting Microneedle Patch for the Treatment of Obesity;Advanced Therapeutics;2024-05-21

2. Recent clinical and pharmacological advancements of incretin-based therapy and the effects of incretin on physiology;Journal of Diabetology;2024-01

3. GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion;Diabetologia;2023-12-21

4. Discovery of ecnoglutide – A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog;Molecular Metabolism;2023-09

5. Short-term and low-dose liraglutide plus metformin decreased body mass index and insulin resistance more than metformin alone in obese women with polycystic ovary syndrome: An open-label randomized controlled study;IMC Journal of Medical Science;2023-09-01